VC fund profile · evidence-aware directory data
Yosemite stages, portfolio and investment profile
Reed Jobs' San Francisco oncology-focused venture investor, independent since 2023. Invests in cancer medicine, diagnostics and care delivery, and also supports separate nonprofit scientific grants. Fund I closed at $263M in 2024, Fund II reached $350M final close disclosed November 4, 2026.
Keep track of Yosemite
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Not recorded
Participates: Seed, Series A, Series B, Growth
Sector focus
Not recorded
Geography
San Francisco, USA
Founded 2023
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
None yet
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.